FDA Okays Smith & Nephew’s Birmingham Hip, But Orders Postmarket Studies

Smith & Nephew will be the first to offer hip resurfacing in the U.S. after FDA approved the firm's Birmingham system May 9

More from Archive

More from Medtech Insight